Position in ESPR
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$35,259,754
New position
Shares Held
11,158,150
first reported quarter
Ownership
4.33%
of shares outstanding
% of Portfolio
26.32%
of 13F equity value
Holder Rank
#1
of 40 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Trium Capital LLP holds $35,259,754 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
11,158,150 | $35,259,754 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,259,754 | 11,158,150 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||